ES8105147A1 - Procedimiento para la obtencion de composiciones farmaceuti-cas de actividad antibacteriana - Google Patents

Procedimiento para la obtencion de composiciones farmaceuti-cas de actividad antibacteriana

Info

Publication number
ES8105147A1
ES8105147A1 ES485561A ES485561A ES8105147A1 ES 8105147 A1 ES8105147 A1 ES 8105147A1 ES 485561 A ES485561 A ES 485561A ES 485561 A ES485561 A ES 485561A ES 8105147 A1 ES8105147 A1 ES 8105147A1
Authority
ES
Spain
Prior art keywords
gram
positive
pharmaceutical compositions
treatment
negative pathogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES485561A
Other languages
English (en)
Other versions
ES485561A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ausonia Farmaceutici SRL
Original Assignee
Ausonia Farmaceutici SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT28934/78A external-priority patent/IT1119708B/it
Priority claimed from IT25973/79A external-priority patent/IT1123321B/it
Application filed by Ausonia Farmaceutici SRL filed Critical Ausonia Farmaceutici SRL
Publication of ES8105147A1 publication Critical patent/ES8105147A1/es
Publication of ES485561A0 publication Critical patent/ES485561A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE COMPOSICIONES FARMACEUTICAS ANTIBIOTICAS. CONSISTE EN ASOCIAR UN ANTIBIOTICO Y UN BETA-CETOACIDO DE FORMULA GENERAL (I), EN EL QUE EN A SE INTRODUCE EL GRUPO CH O UN ATOMO DE NITROGENO; EN B SE APLICA EL ANILLO BENCENICO, UN GRUPO AZINICO O DIAZINICO Y EN R SE INTRODUCE UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO. EL ANTIBIOTICO SE ESCOGE ENTRE CEFALEXINAS, PIRCEFALEXINA, CEFADROXIL Y CEFRATREXINA, EL COMPUESTO I ES ACIDO ANALIDIXICO, ACIDO EXOLINICO, ACIDO PIPEMIDICO, ACIDO PJIROMIDICO O OXACINA. *FORMULA* N
ES485561A 1978-10-20 1979-10-19 Procedimiento para la obtencion de composiciones farmaceuti-cas de actividad antibacteriana Granted ES485561A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT28934/78A IT1119708B (it) 1978-10-20 1978-10-20 Impiego di beta-chetoacidi eterociclici azotati come inibitori del trasferimento di fattori genetici di resistenza
IT25973/79A IT1123321B (it) 1979-09-25 1979-09-25 Composizioni farmaceutiche ad attivita'antibatterica e loro impiego nella terapia di infezioni da germi gram-positivi e gram-negativi

Publications (2)

Publication Number Publication Date
ES8105147A1 true ES8105147A1 (es) 1981-05-16
ES485561A0 ES485561A0 (es) 1981-05-16

Family

ID=26328635

Family Applications (1)

Application Number Title Priority Date Filing Date
ES485561A Granted ES485561A0 (es) 1978-10-20 1979-10-19 Procedimiento para la obtencion de composiciones farmaceuti-cas de actividad antibacteriana

Country Status (8)

Country Link
US (1) US4386070A (es)
CH (1) CH642850A5 (es)
DE (1) DE2942107C2 (es)
ES (1) ES485561A0 (es)
FR (1) FR2439015A1 (es)
GB (1) GB2035800B (es)
PH (1) PH15745A (es)
PT (1) PT70347A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
HU192982B (en) * 1984-04-28 1987-08-28 Allatorvostudomanyi Egyetem Process for producing synergetic pharmaceutical compositions containing thiamulin and antibacterial and antiprotozoal organic acids
HU190963B (en) * 1984-04-28 1986-12-28 Allatorvostudomanyi Egyetem,Hu Process for production of synergyc medical preparatives containing organic acids with oxitetracylin and antimicrobatic influence
FR2563432B1 (fr) * 1985-04-26 1990-02-09 Hajdusagi Agraripari Egyesules Nouvelles compositions pharmaceutiques antibacteriennes et antiprotozoaires comprenant du fumarate acide de tiamuline et procede pour leur preparation
HU200917B (en) * 1987-07-20 1990-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical compositions comprising quinoline or naphthyridinecarboxylic acid and tetracycline derivatives as active ingredient
HUT52959A (en) * 1988-07-19 1990-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of syergethic compositions
CN1048730C (zh) * 1998-04-23 2000-01-26 河南省新乡市第二人民医院 吡哌酸锌、其合成工艺及吡哌酸锌软膏
WO2006071685A2 (en) * 2004-12-20 2006-07-06 Massachusetts Institute Of Technology Antimicrobial combination therapy comprising an antibiotic and toxic compound selected from dna damaging agents, alkylating agents, heavy metal containing compounds and chelating agents
CN110551124B (zh) * 2019-06-14 2021-01-08 山东省联合农药工业有限公司 一种喹诺酮类化合物或其农药学上可接受的盐及其制备方法与用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035791A1 (en) * 1969-03-31 1970-12-24 Italchemi Srl Antibacterial compn contg neomycin
ZA703732B (en) * 1969-06-04 1971-01-27 Seiyaku D Co Ltd Anti-bacterial composition

Also Published As

Publication number Publication date
PH15745A (en) 1983-03-18
DE2942107C2 (de) 1986-10-02
FR2439015A1 (fr) 1980-05-16
US4386070A (en) 1983-05-31
DE2942107A1 (de) 1980-04-30
PT70347A (fr) 1979-11-01
GB2035800B (en) 1983-03-09
GB2035800A (en) 1980-06-25
CH642850A5 (it) 1984-05-15
ES485561A0 (es) 1981-05-16
FR2439015B1 (es) 1983-03-18

Similar Documents

Publication Publication Date Title
IE36209L (en) Substituted 2,2'-methylenediphenols
EP0266576A3 (en) 1-tert-alkyl-substituted naphthyridine and quinoline carboxylic acids as antibacterial agents
ES8105147A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas de actividad antibacteriana
ES445913A1 (es) Un procedimiento para la preparacion de una sal dibasica farmaceuticamente aceptable de m. m. 17880.
EP0196628A3 (en) Ansamycin antibioticum, microbiological process for its preparation and its use as a medicament
GB865796A (en) A 5-nitro-2-furyl compound
JPS57143000A (en) Antibiotic compound, manufacture and medical use
FR2361114A1 (fr) Procede de preparation d'analogues de cephalosporine a propriete antibacterienne et nouveaux produits ainsi obtenus
JPS5663917A (en) Synergistic microbial infection treating composition
IE44433L (en) Derivatives of thienamycin and its isomers
IE37892L (en) Antibiotic a.2315.
IE40057L (en) 4- oxo -1- pyridinyl penicillin and cephalosporin¹derivatives
ES8707251A1 (es) Un metodo para producir n-desacetil-antibiotico tan-588
DE3260276D1 (en) Peptide antibiotic, component a, process for its preparation and its use in medicines
DE3373307D1 (en) 2-oxoazetidinone derivatives, their production and use
ATE36712T1 (de) Nargenicin c1.
GB1028563A (en) Antibacterial derivative of 7-aminocephalosporanic acid
FR2267791B1 (es)
FR2157811A1 (en) (6-substd) imidazo (2,1-b) thiazole compsns - plant antibacterial agents
JPS54151132A (en) Compound having antibiotic activity
AU232392B2 (en) Pharmaceutical compositions for bacterial and/or fungal infections ofman and animals
AU268053B2 (en) Veterinary remedies against protozoan and bacterial infections
AU4628459A (en) Pharmaceutical compositions for bacterial and/or fungal infections ofman and animals
AU953161A (en) Veterinary remedies against protozoan and bacterial infections
AU242277B2 (en) Antibacterial compositions